Pharmacogenetic testing for thiopurine drugs in Brazilian acute lymphoblastic leukemia patients-Reference-Cited by-同舟云学术

Pharmacogenetic testing for thiopurine drugs in Brazilian acute lymphoblastic leukemia patients

Published:2023-01 Issue: Volume:78 Page:100214
ISSN:1807-5932
Container-title:Clinics
language:en
Short-container-title:Clinics

Author:

Suarez-Kurtz Guilherme^ORCID,Almeida Cristina Wiggers,Chapchap Eduardo,Schramm Márcia Trindade,Ikoma-Coltutato Maura Rosane Valério,Lins Mecneide Mendes,Fonseca Teresa Cristina Cardoso,Aguiar Thais Ferraz,Emerenciano Mariana^ORCID

Funder

Conselho Nacional de Desenvolvimento Científico e Tecnológico

Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro

Publisher

Elsevier BV

Subject

General Medicine

Reference7 articles.

1. Pharmacogenetic testing in oncology: a Brazilian perspective;Suarez-Kurtz;Clinics,2018

2. Implementation of a pharmacogenomic program in a Brazilian public institution;Suarez-Kurtz;Pharmacogenomics,2020

3. IKZF1 deletions associate with CRLF2 overexpression leading to a poor prognosis in B- cell precursor acute lymphoblastic leukaemia;Maciel;Transl Oncol,2022

4. Clinical pharmacogenetics implementation consortium guideline for thiopurine dosing based on TPMT and NUDT15 genotypes;Relling;Clin Pharmacol Ther,2019

5. Thiopurine methyltransferase phenotypes and genotypes in Brazilians;Reis;Pharmacogenetics,2003

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. NUDT15 and TPMT polymorphisms in three distinct native populations of the Brazilian Amazon;Frontiers in Pharmacology;2024-02-06

2. The c.415C>T polymorphism in NUDT15 is more frequent than the polymorphisms in TPMT in Chilean patients who use thiopurine drugs;Pharmacogenetics and Genomics;2023-09-27